Dermapharm Holding SE
DMPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $3 | $3 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27.2% | -10% | 4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36.4% | 67.7% | 65.9% | 66.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.8% | 24.3% | 27.3% | 24.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14% | 7.7% | 11% | 7.1% |
| EPS Diluted | 0.9 | 0.39 | 0.62 | 0.38 |
| % Growth | 130.8% | -37.1% | 63.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |